M. Pinto

Convalescent Plasma in COVID-19. Mortality-Safety First Results of the Prospective Multicenter FALP 001-2020 Trial

H. Marsiglia, M. Balcells, B. Nervi, 2020, medRxiv.

COVID-19 Survivors' Reports of the Timing, Duration, and Health Impacts of Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection

J. Borelli, N. Lambert, R. Chakraborty, 2021, medRxiv.

SARS-CoV-2 BA.5 vaccine breakthrough risk and severity compared with BA.2: a case-case and cohort study using Electronic Health Records in Portugal

J. P. Almeida, J. Isidro, V. Borges, 2022, medRxiv.

The effect of SARS-CoV-2 variant on respiratory features and mortality

Y. Huang, N. Lambert, R. Chakraborty, 2022, Scientific Reports.

Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike’s Dynamics

Marcelo A. Navarrete, S. Pantano, Á. Olivera-Nappa, 2021, Viruses.

Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2)

J. P. Almeida, E. Fernandes, J. Isidro, 2022, medRxiv.